India · Delayed Price · Currency is INR Zenlabs Ethica Company Description
Zenlabs Ethica Limited engages in the marketing and distribution of pharmaceutical products in India.
It markets analgesics and anti-inflammatory drugs; skin preparations; drugs for neurological and GIT disorders; ear, eye, and nasal drops; anti-diabetic, anti-depressant, anti-infective, anti-emetic, anti-hypertensive, anti-allergic, and anti-cold and cough syrups; steroids and anabolic steroids; nutraceuticals; antacids, enzymes, and appetite stimulants; ayurvedic preparations; soaps; dusting powders; soaps; and other pharmaceutical drugs.
The company is also involved in the private label manufacturing of various pharmaceutical products, such as tablets, capsules, injections, syrups, and ointments; and therapeutics, such as anti-infective, anti-obesity, anti-bacterial, anti-hypertensives, anti-fungal, pain killers, and nutritional supplements.
It serves customers through a network of distributors and stockists in Myanmar, Indonesia, Malaysia, Thailand, Cambodia, Vietnam, Laos, the Philippines, Singapore, Brunei, Timor-Leste, Bangladesh, and internationally.
The company was formerly known as Neelkanth Technologies Limited and changed its name to Zenlabs Ethica Limited in January 2016.
Zenlabs Ethica Limited was incorporated in 1993 and is based in Chandigarh, India.
| Country | India |
| Founded | 1993 |
| Industry | Drugs, Drug Proprietaries, and Druggists' Sundries |
| Employees | 65 |
| CEO | Sanjeev Singal |
Contact Details
Address: Plot No. 194-195 Chandigarh, 160002 India | |
| Phone | 91 17 2465 1105 |
| Website | zenlabsethica.com |
Stock Details
| Ticker Symbol | 530697 |
| Exchange | Bombay Stock Exchange |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Sanjeev Singal | Chief Executive Officer |
| Adarsh Sharma | Chief Financial Officer |